Drugs / autologous muscle-derived cells (AMDC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02291432 | Feb 2015 → Jun 2019 | urinary system disorder | Cook MyoSite | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous muscle-derived cells (AMDC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02291432 ↗ |
| Known as | AMDC-USR | “Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR)” NCT02291432 ↗ |